It's not capital expenditure on Deloraine that is the problem, it's the Operating expenses.
For every $10M of Sales bubs makes, it losses $1M cash, excluding operating expenses. It cost BUBS $11,755,000 cash to manufacture $10,676,000 sales.
If you cut advertising and marketing - sales goes down.
If you cut staff costs - No SAMR, No USFDA.
If you cut admin and corporate costs - No SAMR, No USFDA, No Court cases.
this is not worth $75M Market Cap
It's not capital expenditure on Deloraine that is the problem,...
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $129.3M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 15.0¢ | 14.5¢ | $218.8K | 1.502M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1163865 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 1553235 | 27 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
14.8¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 14.8¢ | 14.8¢ | 14.5¢ | 375198 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| BUB (ASX) Chart |